Rectal Nonsteroidal Anti-inflammatory Drugs to Reduce the Rate and Severity of Pancreatitis After Endoscopic Retrograde Cholangiopancreatography: Still Grappling With Fundamental Questions.

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 Rectal Nonsteroidal Anti-inflammatory Drugs to Reduce the Rate and Severity of Pancreatitis After Endoscopic Retrograde Cholangiopancreatography: Still Grappling With Fundamental Questions 68 69 70 71 72 73 74 75 76 77 78 See “Rectal indomethacin reduces pancreatitis in highand low-risk patients undergoing endoscopic retrograde cholangiopancreatography,” by Thiruvengadam NR, Forde K, Ma GK, et al, on page 000.

[1]  G. Ginsberg,et al.  Rectal Indomethacin Reduces Pancreatitis in High- and Low-Risk Patients Undergoing Endoscopic Retrograde Cholangiopancreatography. , 2016, Gastroenterology.

[2]  R. Kozarek,et al.  Take 2 Indomethacin (Suppositories) and Call Me in the Morning? The Role of Nonsteroidal Anti-inflammatory Drugs in Protection Against Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. , 2016, Gastroenterology.

[3]  B. Lacy,et al.  Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients. , 2016, Gastroenterology.

[4]  M. Sajid,et al.  Systematic review and meta-analysis on the prophylactic role of non-steroidal anti-inflammatory drugs to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis. , 2015, World journal of gastrointestinal endoscopy.

[5]  U. Hayat,et al.  A Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in Patients with Suspected Type 3 Sphincter of Oddi Dysfunction , 2015, Digestive Diseases and Sciences.

[6]  D. Nicolás-Pérez,et al.  Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Cost-effectiveness Analysis , 2015, Pancreas.

[7]  Vikesh K. Singh,et al.  Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials. , 2015, Gastrointestinal endoscopy.

[8]  B. Han,et al.  Rectal NSAIDs for the prevention of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials. , 2014, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

[9]  V. Wadhwa,et al.  A Meta-Analysis on the Role of Rectal Diclofenac and Indomethacin in the Prevention of Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis , 2014, Pancreas.

[10]  H. Yuhara,et al.  Pharmacologic prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis: protease inhibitors and NSAIDs in a meta-analysis , 2014, Journal of Gastroenterology.

[11]  A. Barkun,et al.  Meta‐analysis: rectal indomethacin for the prevention of post‐ERCP pancreatitis , 2013, Alimentary pharmacology & therapeutics.

[12]  X. Zou,et al.  Nonsteroidal anti-inflammatory drugs for prevention of post-ERCP pancreatitis: a meta-analysis. , 2012, Gastrointestinal endoscopy.

[13]  Richard S. Kwon,et al.  A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. , 2012, The New England journal of medicine.

[14]  Mohamed O. Othman,et al.  Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review. , 2011, Gastrointestinal endoscopy.

[15]  T. Takayama,et al.  Prophylactic pancreatic stent placement and post-ERCP pancreatitis: a systematic review and meta-analysis , 2010, Endoscopy.

[16]  D. Adler,et al.  Dye-free Wire-guided Cannulation of the Biliary Tree During ERCP is Associated With High Success and Low Complication Rates: Outcomes in a Single Operator Experience of 822 Cases , 2010, Journal of clinical gastroenterology.

[17]  M. Khoshbaten,et al.  Role of diclofenac in reducing post‐endoscopic retrograde cholangiopancreatography pancreatitis , 2008, Journal of gastroenterology and hepatology.

[18]  P. Lankisch.  Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP. , 2008, The American journal of gastroenterology.

[19]  A. Ojeda,et al.  Efecto de la administración de indometacina rectal sobre los niveles séricos de amilasa posteriores a colangiopancreatografía retrógrada endoscópica y su impacto en la aparición de episodios de pancreatitis secundaria , 2007 .

[20]  B. Petersen,et al.  Establishing a true assessment of endoscopic competence in ERCP during training and beyond: a single-operator learning curve for deep biliary cannulation in patients with native papillary anatomy. , 2006, Gastrointestinal endoscopy.

[21]  A. Ojeda,et al.  Effect of the rectal administration of indomethacin on amylase serum levels after endoscopic retrograde cholangiopancreatography , and its impact on the development of secondary pancreatitis episodes , 2007 .

[22]  Olusola Oiofinlade.  Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. , 2004, Gastroenterology.